✦ LIBER ✦

Fas (CD95/Apo-1) ligand regulation in T cell homeostasis, cell-mediated cytotoxicity and immune pathology

✍ Scribed by Thomas Brunner; Christoph Wasem; Ralph Torgler; Igor Cima; Sabine Jakob; Nadia Corazza

Book ID: 117701358
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 331 KB
Volume: 15
Category: Article
ISSN: 1044-5323
DOI: 10.1016/s1044-5323(03)00035-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regulation of cell surface APO-1/Fas (CD

Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases

✍ Sara M. Mariani; Bernd Matiba; Caroline Bäumler; Peter H. Krammer 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 535 KB

Function and regulation of the CD95 (APO

Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system

✍ Min Li-Weber; Peter H. Krammer 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 454 KB

Immune down-regulation and peripheral de

Immune down-regulation and peripheral deletion of CD8 T cells does not require TNF receptor-ligand interactions nor CD95 (Fas, APO-1)

✍ Arno Reich; Heinrich Körner; Jonathon D. Sedgwick; Hanspeter Pircher 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

INTERFERON α AUGMENTS ACTIVATION-INDUCED

INTERFERON α AUGMENTS ACTIVATION-INDUCED T CELL DEATH BY UPREGULATION OF FAS (CD95/APO-1) AND FAS LIGAND EXPRESSION

✍ Arthur Kaser; Shigekazu Nagata; Herbert Tilg 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 280 KB

Fas and Fas ligand in discordant xenogen

Fas and Fas ligand in discordant xenogeneic antibody-dependent cell-mediated cytotoxicity

✍ I Fujiwara; H Nakajima; T Matsuda; N Mizuta; H Yamagishi; T Oka 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Regulation of CD95 (APO-1/ FAS) ligand a

Regulation of CD95 (APO-1/ FAS) ligand and receptor expression in squamous-cell carcinoma by interferon-γ and cisplatin

✍ Cordula Moers; Ulrich Warskulat; Markus Müschen; Jos Even; Dieter Niederacher; R 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 337 KB 👁 2 views

CD95 (Apo-1/Fas) ligand (CD95L) expression has been observed in various malignancies. In human primary cell lines from a squamous cell carcinoma (SCC) of the vulva, the effect of cisplatin (CDDP) and IFN␥ on the expression of CD95L and its 2 receptor isoforms, CD95 transmembrane (CD95tm) and CD95 so